top of page
C2i Photo 1_edited_edited.jpg

Comprehensive Virology Services
At The Cutting Edge Of Science

以最尖端的科技提供全方位病毒學服務和諮詢

A Service Platform For Academia & Industry Specialising In Infectious Diseases

提供傳染病學的產學研服務平台

Learn More

Built on research from the world’s premier respiratory virus research hub in
Hong Kong

以全球首屈一指的呼吸道病毒研究中心的研究為基礎​

State-of-art world class cell/organ culture laboratory for personalized respiratory tract platform

以世界最先進的細胞/器官培養實驗室研發個性化的呼吸道平台

World leading scientists in Influenza virus and Coronavirus research, as the No.1 institution in Asia ranks 3rd in COVID-19 and 4th in Influenza

匯聚亞洲排名第一院校、 COVID-19 研究中排名第三、流感研究中排名第四的科學家研究團隊

Services

Services

服務

Risk assessment of newly emerging respiratory viruses

新發呼吸道病毒的風險評估

In vitro, in vivo and ex vivo assays specific for influenza viruses  and coronaviruses in BSL2 and BSL3 labs.

在二級及三級生物安全實驗室以體外、體內和離體模型進行針對流感病毒和冠狀病毒的風險評估。

C2iTech Website 1.png

Anti-viral test

抗病毒測試

Our viral infected ex-vivo and organoid models for various respiratory viruses (influenza viruses and coronaviruses) can help to evaluate the efficacy of antiviral drugs / compounds.

我們提供各種呼吸道病毒(流感病毒和冠狀病毒)的病毒感染離體和類器官模型作為抗病毒藥物/化合物的安全及功效測試。

C2iTech Website 2.png

Assessment: 

  • Drug induced cytotoxicity (CCK8) 

  • Virus replication kinetics (TCID50, qPCR) 

  • Pro-inflammatory cytokine profile (qPCR, flow cytometry) 

  • Viral tropism (staining)

Platforms - for testing diagnostic, therapeutic, and antiviral products, and vaccines

技術平台 - 用於診斷治療、抗病毒藥物和疫苗研制

C2iTech Website 3.png

Respiratory Organoid Platform (ROP)

呼吸類器官平台 (ROP)

Personalised risk assessment platform for ROP 作為個性化風險評估平台: 

  • Predicting the infectivity of emerging respiratory viruses and host response to the viruses
    預測新發呼吸道病毒的傳染性和宿主對病毒的反應

  • Evaluating treatment responses 評估(藥物)治療效果

  • Developing personalized medicine 開發個性化醫療

C2iTech Website 4.png

Personalised platforms of human respiratory tract

人體呼吸道個性化平台

C2iTech Website 5.png

Characteristics of airway organoids 氣道類器官的特徵

Picture 7.png
C2I_full_lockup_horizontal_rgb_Blue.png

Centre for

Immunology & Infection

C2iTech is a spin-off company of the Centre for Immunology & Infection (C2i), a major initiative fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur.

bottom of page